Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01282112 · ClinicalTrials.gov registry record
Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 416
- Enrollment target
NCT01282112 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 416 participants.
The verdict
NCT01282112 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 416 participants
- Enrollment target
Study Summary
This is a retrospective chart review study (700 charts from 2002 to 2010)of children from 0 to 18 years of age who have undergone Brainstem Evoked Auditory Response (BEAR)testing using midazolam and pentobarbital protocol for moderate sedation. The specific aims of this study are two-fold: 1. to determine the efficacy of intravenous pentobarbital during BEAR testing in the pediatric population using a standardized protocol; and 2. to evaluate the incidence of adverse events (major and minor), paradoxical reaction and failed sedation and identify predictors for failure and adverse events if any.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01282112
The ClinicalTrials.gov registry entry for NCT01282112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 416 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01282112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01282112 about?
NCT01282112 is a clinical study titled "Sedation for Brainstem Evoked Auditory Response (BEAR) Testing Using Intravenous Pentobarbital". This is a retrospective chart review study (700 charts from 2002 to 2010)of children from 0 to 18 years of age who have undergone Brainstem Evoked Auditory Response (BEAR)testing using midazolam and pentobarbital protocol for moderate sedation. The specific aims of this study are two-fold: 1. to de...
What is the current status of trial NCT01282112?
This trial is currently completed. The enrollment target is 416 participants. The study started on 2011-01. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01282112?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.